PeptideLabs Logo
PeptideLabs
All profiles

Thymalin

Non-standardised blend · Immune research

Linked to immune and ageing themes. Composition, evidence and regulatory status are not internationally standardised.

Not FDA/EMA approved
LibraryNo account · this device only

Also known as: Thymus peptide complex · Thymic extract peptides

Use at a glance

Thymalin

Linked to immune and ageing themes. Composition, evidence and regulatory status are not internationally standardised.

No reliable information available

No sufficiently clear source for amounts, intervals and cycles can be assigned to this profile. Concrete stages are therefore intentionally omitted; an invented number would be more dangerous than a visible data gap.

How is it used?
Identify every ingredient and its amount first. The same blend name can refer to different products.
Does it need mixing?
Without individual amounts and joint stability data there is no verified recipe. Correct arithmetic does not establish compatibility.
View preparationCheck sources
More factsNon-standardised blend · Immune research
Classification
Non-standardised blend · Immune research
Research focus
Linked to immune and ageing themes. Composition, evidence and regulatory status are not internationally standardised.
Evidence
Anecdotal
Status
Not FDA/EMA approved

This entry is not a single peptide, or its use depends on diagnosis, product form or composition. A blanket peptide dose would be misleading.

Schedule explained in detailNo uniform peptide protocol

Amount status

No reference page and no single defined active substance: thymalin denotes a historically animal-derived polypeptide extract/complex with variable composition.

Profile evidence level: anecdotal.

Timing

No standardised timing.

No individual recommendation.

Cycle/duration

Old, heterogeneous studies do not produce a modern community cycle.

No individual recommendation.

Mixing & calculations

Without individual amounts and joint stability data there is no verified recipe. Correct arithmetic does not establish compatibility.

All preparation informationProduct details and calculation examples from the available sources.

No universal dose or reconstitution without the manufacturing method, protein profile, exact composition and batch testing.

Reconstitution & quantitiesOpen basics, units and sources
Explained in very simple termsBefore reading any number: this page reports what a product label, study or online community states. It does not say what any person should use.

Amount

mg or µg describe the mass of a substance. That is not the same as ml of fluid or U on a syringe. The number is only the amount stated by the identified source.

Interval

The interval only describes the time stated between two points. For example, once every 7 days does not mean daily and never justifies catching up or doubling.

Cycle

A cycle is a stated period that may include breaks. A community cycle proves neither effectiveness nor safety and does not prevent long-term risks.

Reconstitution

Reconstitution means mixing powder with a defined volume of fluid. This changes concentration, not the total amount in the vial. On U-100, 100 U equals exactly 1 ml of volume.

Not a guide to misuse

All community figures are shown only to place widely circulated online protocols in context. They are not instructions for self-use, injection, performance enhancement or any other misuse. Approved figures apply only to the exact named product, approved indication and medical supervision.

Research, risks & more detailsMechanism, adverse effects, storage, comparisons and common questions.

Mechanism: what is supported and what does not follow

Non-standardised thymus-derived peptide preparation name

Thymalin is classified as “Non-standardised thymus-derived peptide preparation name”. Linked to immune and ageing themes. Composition, evidence and regulatory status are not internationally standardised. This describes the investigated pathway but does not validate a community use, amount, route or combination.

01

Thymus-derived blend

This concerns blends of peptides originally identified from thymus tissue and linked to immune maturation, similar to a collection of related signals rather than one single defined agent. Individual components are studied more often than the blend as a whole.

02

Immune-modulating peptide

This studies how a peptide adjusts immune cell activity, similar to a dial that strengthens or dampens the immune response. Immune cell counts and inflammation markers are measured in studies.

03

Product identity testing

This concerns laboratory analysis used to determine what a product actually contains, similar to checking the ingredients label against what's really inside the package. Researchers or analysts typically use chemical testing methods to identify and quantify the actual contents.

What communities discuss

These themes describe discussions and vendor claims. They do not prove benefit, safety, product identity or suitable use.

General wellness forums

Broader wellbeing impressions such as mood, sleep, and general feeling after using various products are exchanged here, usually without structured tracking. Such general impressions are not a substitute for targeted clinical examination.

Anti-aging forums

Combinations of growth-axis, mitochondrial, and skin peptides are compared here with the goal of influencing visible or felt signs of ageing, often documented personally over years. Anecdotes and vendor advertising about slowed ageing are not scientific proof.

Catalog name confusion

Users try to clarify what actual substance lies behind unclear vendor names or code labels, often by comparing labels and vendor claims. Such forum guesses are not a reliable identification of a substance.

Adverse effects and safety risks

  • Modulating immune or antimicrobial signalling can affect inflammation, hypersensitivity, infection risk and unpredictable immune responses; route and formulation matter.
  • Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
  • A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.

Do not self-use / obtain clinical review

  • Autoimmune disease, transplantation, immunosuppression, active infection, cancer and pregnancy require specialist assessment.
  • Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
  • Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.

Monitoring and laboratory markers

  • Depending on indication, blood count, inflammatory markers, infection signs, liver/kidney function and immune parameters may be relevant; no universal community schedule exists.
  • Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.

Evidence boundary

Anecdotal

Composition, evidence and regulatory status are not internationally standardised.

Clinical evidence

Claims rely mostly on personal experience reports and vendor statements rather than controlled studies.

Thymalin refers to a non-standardised preparation from thymus tissue, unlike the single, defined molecule thymosin alpha-1.

Storage and stability

  • The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
  • Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
  • Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.

Troubleshooting and common errors

  • U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
  • Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
  • Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
  • Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.

Regulatory status and WADA

Not FDA/EMA approved

No FDA- or EMA-approved medicinal product; efficacy and safety are not established.

WADA 2026

The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.

WADA — 2026 Prohibited List

Combinations / stacks

  • Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
  • Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
  • Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.

Frequently asked questions

Is an amount shown here a recommendation?

No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.

Does the U-100 calculator prove correct use?

No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.

Can this profile be combined with other substances?

Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.

Which source controls when information conflicts?

For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.

Are community claims clinical evidence?

No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.

Back to all 64 profilesOpen scientific atlas profile